Literature DB >> 9435760

Twelve-month outcome after a first hospitalization for affective psychosis.

S M Strakowski1, P E Keck, S L McElroy, S A West, K W Sax, J M Hawkins, G F Kmetz, V H Upadhyaya, K C Tugrul, M L Bourne.   

Abstract

BACKGROUND: We studied the 12-month course of illness after a first hospitalization for affective psychosis to identify potential outcome predictors in this rarely studied patient population.
METHODS: For this study, 109 patients consecutively admitted for their first psychiatric hospitalization for treatment of affective psychosis were recruited. Diagnostic, symptomatic, and functional evaluations were obtained at the index hospitalization and at 2, 6, and 12 months after discharge to assess syndromic, symptomatic, and functional outcome predictors. Factors associated with outcome were identified by means of multivariate analyses.
RESULTS: Fifty-six percent of the patients achieved syndromic recovery during the 12-month follow-up. Full treatment compliance was associated with more frequent and rapid syndromic recovery. Full compliance was more common in white patients and in patients without substance abuse. Only 35% of these patients achieved symptomatic recovery during this same 12-month interval, and, similarly, only 35% achieved functional recovery. Symptomatic recovery was delayed in patients with substance abuse and was associated with higher socioeconomic status. Higher socioeconomic status was also associated with functional recovery, as was good premorbid function.
CONCLUSIONS: Few patients achieved a favorable outcome in the year after a first hospitalization for an affective psychosis. Low socioeconomic status, poor premorbid function, treatment noncompliance, and substance abuse were associated with lower rates or delayed onset of recovery.

Entities:  

Mesh:

Year:  1998        PMID: 9435760     DOI: 10.1001/archpsyc.55.1.49

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  47 in total

Review 1.  Functional impairment and cognition in bipolar disorder.

Authors:  C A Zarate; M Tohen; M Land; S Cavanagh
Journal:  Psychiatr Q       Date:  2000

2.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

3.  Emotion in bipolar I disorder: Implications for functional and symptom outcomes.

Authors:  Sheri L Johnson; Jordan A Tharp; Andrew D Peckham; Kaja J McMaster
Journal:  J Abnorm Psychol       Date:  2015-10-19

Review 4.  Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials.

Authors:  Dennis A Revicki; Louis S Matza; Emuella Flood; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 5.  Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment.

Authors:  Michael Strober; Boris Birmaher; Neal Ryan; David Axelson; Sylvia Valeri; Henrietta Leonard; Satish Iyengar; Mary Kay Gill; Jeffrey Hunt; Martin Keller
Journal:  Bipolar Disord       Date:  2006-08       Impact factor: 6.744

6.  Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study.

Authors:  Susan J Wenze; Michael F Armey; Ivan W Miller
Journal:  Behav Modif       Date:  2014-01-08

7.  Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder.

Authors:  Boaz Levy; Anna Marie Medina; Kathryn Hintz; Roger D Weiss
Journal:  Psychiatry Res       Date:  2010-07-31       Impact factor: 3.222

Review 8.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

9.  Shared genetic factors influence risk for bipolar disorder and alcohol use disorders.

Authors:  N Carmiol; J M Peralta; L Almasy; J Contreras; A Pacheco; M A Escamilla; E E M Knowles; H Raventós; D C Glahn
Journal:  Eur Psychiatry       Date:  2013-12-08       Impact factor: 5.361

10.  The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-12       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.